Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.
Gabellone S, Vanni S, Fausti V, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Cavaliere D, Pacilio CA, Ercolani G, Pieri F, Gurrieri L, Riva N, Jones R, De Vita A. Gabellone S, et al. Among authors: spadazzi c. Heliyon. 2024 Nov 22;10(23):e40596. doi: 10.1016/j.heliyon.2024.e40596. eCollection 2024 Dec 15. Heliyon. 2024. PMID: 39687122 Free PMC article. Review.
Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research.
Giusti V, Miserocchi G, Sbanchi G, Pannella M, Hattinger CM, Cesari M, Fantoni L, Guerrieri AN, Bellotti C, De Vita A, Spadazzi C, Donati DM, Torsello M, Lucarelli E, Ibrahim T, Mercatali L. Giusti V, et al. Among authors: spadazzi c. Biomedicines. 2024 Aug 21;12(8):1921. doi: 10.3390/biomedicines12081921. Biomedicines. 2024. PMID: 39200384 Free PMC article. Review.
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment.
Vanni S, Miserocchi G, Gallo G, Fausti V, Gabellone S, Liverani C, Spadazzi C, Cocchi C, Calabrese C, De Luca G, Bassi M, Gessaroli M, Tomasetti N, Campobassi A, Pieri F, Ercolani G, Cavaliere D, Gurrieri L, Riva N, Recine F, Ibrahim T, Mercatali L, Jones R, De Vita A. Vanni S, et al. Among authors: spadazzi c. Exp Hematol Oncol. 2024 Aug 5;13(1):74. doi: 10.1186/s40164-024-00540-4. Exp Hematol Oncol. 2024. PMID: 39103896 Free PMC article.
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.
Marchesini M, Gherli A, Simoncini E, Tor LMD, Montanaro A, Thongon N, Vento F, Liverani C, Cerretani E, D'Antuono A, Pagliaro L, Zamponi R, Spadazzi C, Follini E, Cambò B, Giaimo M, Falco A, Sammarelli G, Todaro G, Bonomini S, Adami V, Piazza S, Corbo C, Lorusso B, Mezzasoma F, Lagrasta CAM, Martelli MP, La Starza R, Cuneo A, Aversa F, Mecucci C, Quaini F, Colla S, Roti G. Marchesini M, et al. Among authors: spadazzi c. Nat Commun. 2024 Jun 4;15(1):4739. doi: 10.1038/s41467-024-48953-3. Nat Commun. 2024. PMID: 38834613 Free PMC article.
High-grade transformation of a polymorphous adenocarcinoma of the salivary gland: a case report and review of the literature.
Miserocchi G, Bassi M, De Luca G, Calpona S, De Rosa F, Bongiovanni A, Parisi E, Di Menna G, De Vita A, Liverani C, Spadazzi C, Cocchi C, Vanni S, Capelli L, Magnani M, Meccariello G, Vicini C, Campobassi A, Mercatali L, Ibrahim T. Miserocchi G, et al. Among authors: spadazzi c. Front Oncol. 2023 Sep 18;13:1245043. doi: 10.3389/fonc.2023.1245043. eCollection 2023. Front Oncol. 2023. PMID: 37795450 Free PMC article.
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
Vanni S, Fausti V, Fonzi E, Liverani C, Miserocchi G, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Riva N, Recine F, Casadei R, Pieri F, Guerrieri AN, Serra M, Ibrahim T, Mercatali L, De Vita A. Vanni S, et al. Among authors: spadazzi c. Int J Mol Sci. 2023 Apr 8;24(8):6926. doi: 10.3390/ijms24086926. Int J Mol Sci. 2023. PMID: 37108089 Free PMC article.
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors.
Liverani C, Spadazzi C, Ibrahim T, Pieri F, Foca F, Calabrese C, De Vita A, Miserocchi G, Cocchi C, Vanni S, Ercolani G, Cavaliere D, Ranallo N, Chiadini E, Prisinzano G, Severi S, Sansovini M, Martinelli G, Bongiovanni A, Mercatali L. Liverani C, et al. Among authors: spadazzi c. Front Endocrinol (Lausanne). 2023 Jan 20;13:1045038. doi: 10.3389/fendo.2022.1045038. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743926 Free PMC article.
The emerging role of cancer nanotechnology in the panorama of sarcoma.
Mercatali L, Vanni S, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Fausti V, Riva N, Genovese D, Lucarelli E, Focarete ML, Ibrahim T, Calabrò L, De Vita A. Mercatali L, et al. Among authors: spadazzi c. Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36324885 Free PMC article. Review.
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.
Ranallo N, Iamurri AP, Foca F, Liverani C, De Vita A, Mercatali L, Calabrese C, Spadazzi C, Fabbri C, Cavaliere D, Galassi R, Severi S, Sansovini M, Tartaglia A, Pieri F, Crudi L, Bianchini D, Barone D, Martinelli G, Frassineti GL, Ibrahim T, Calabrò L, Berardi R, Bongiovanni A. Ranallo N, et al. Among authors: spadazzi c. Cancers (Basel). 2022 Jun 30;14(13):3231. doi: 10.3390/cancers14133231. Cancers (Basel). 2022. PMID: 35805003 Free PMC article.
51 results